Differentiating Visual Symptoms in Retinal Migraine and Migraine With Aura: A Systematic Review of Shared Features, Distinctions, and Clinical Implications
Abstract
The objective of this study is to systematically review and compare the visual symptoms, temporal characteristics, associated features, and pathophysiological mechanisms of retinal migraine (RM) and migraine with aura (MA) to facilitate clinical differentiation. Following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, databases (PubMed, Google Scholar, Web of Science, and Scopus) were searched from January 1985 to July 2025 for studies on adult patients with RM or MA. A large language model assisted in extracting data on study design, visual symptoms, diagnostic criteria, and frequencies. Inclusion criteria focused on studies differentiating conditions, with preference given to case series of at least five patients and to systematic reviews or meta-analyses that encompassed at least 10 studies. Two-stage screening yielded 171 papers, with 65 unique studies analyzed qualitatively. RM is characterized by monocular (90%), negative symptoms (e.g., scotoma 84% and transient vision loss up to 100%), variable duration (less than 60 minutes in 89%, but prolongable), and vascular pathophysiology, with rare permanent loss. MA features bilateral/homonymous (75%), positive symptoms (e.g., scintillating scotoma 77% and zigzag 53%), stereotyped duration (five to 60 minutes in 79%), and cortical spreading depression, often with additional neurological symptoms. Overlaps include transient phenomena (less than one hour) and gradual spread. The…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.